SCHEMBL3405563

SCHEMBL3405563

COc1ccc2c(c1)c(CN(C)CCN1CCC(c3ccccc3)(N(C)C)CC1)c(C)n2Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 11/20 0.51
PLA2G1B P04054 1/20 0.51
TSHR P16473 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HTT P42858 1/20 0.47
MAPK1 P28482 2/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
PMP22 Q01453 2/20 0.43
MEN1 O00255 1/20 0.43
RGS12 O14924 1/20 0.43
MAPT P10636 1/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
GNAI1 P63096 1/20 0.43
HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734729 0.86 PLA2G2A (0.50) PLA2G2APLA2G1BTSHRALDH1A1HTT
SCHEMBL3408009 0.76 HTR6 (0.55) CYP1A2CYP2C9
SCHEMBL4092313 0.76 TSHR (0.47) PLA2G2APLA2G1BTSHRALDH1A1HTT
SCHEMBL3403647 0.75 PLA2G2A (0.46) PLA2G2APLA2G1BTSHRALDH1A1HTT
SCHEMBL3405578 0.75 OPRM1 (0.38) HTTMAPK1KMT2AMEN1MAPT
SCHEMBL7694484 0.71 PLA2G2A (0.73) PLA2G2APLA2G1BTSHRALDH1A1MAPK1
Benanserin SCHEMBL30261849 0.69 PLA2G2A (0.76) PLA2G2APLA2G1BTSHRALDH1A1MAPK1
Benanserin SCHEMBL2734622 0.69 PLA2G2A (0.76) PLA2G2APLA2G1BTSHRALDH1A1MAPK1
Benanserin SCHEMBL1801669 0.68 PLA2G2A (0.74) PLA2G2APLA2G1BTSHRALDH1A1MAPK1
SCHEMBL7963016 0.68 PLA2G2A (1.00) PLA2G2APLA2G1BTSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP claimed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 PLA2G2A 2300/4885PLA2G1B 1434/4885TSHR 2971/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 PLA2G2A 2300/4885PLA2G1B 1434/4885TSHR 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.